Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Blood (2024) 144 (15): 1570–1580.

https://doi.org/10.1182/blood.2023023754

Published: 2024

Includes: Supplemental data

Journal Articles

Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1 + acute lymphoblastic leukemia

Pierre Walczak, Sofiane Fodil, Nicolas Vignal, Aurélie Cabannes-Hamy, Nicolas Boissel, Emmanuel Raffoux, Jean-Michel Cayuela, Lauriane Goldwirt, Etienne Lengliné

Blood (2024) 144 (10): 1127–1130.

https://doi.org/10.1182/blood.2024024838

Published: 2024

Journal Articles

NGS-Based Stratification Refines the Risk Stratification in T-ALL and Identifies a Very High-Risk Subgroup of Patients

Blood (2023) 142 (Supplement 1): 844.

https://doi.org/10.1182/blood-2023-179298

Published: 2023

Journal Articles

Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report

Blood (2023) 142 (Supplement 1): 518.

https://doi.org/10.1182/blood-2023-179192

Published: 2023

Journal Articles

Should the Carbon Footprint of Care be Taken into Account When Choosing a Treatment for Lymphoma? a Case Application on Mantle Cell Lymphoma

Max Piffoux, Aurélie Cabannes-Hamy, Hajer Ben Souda, Olivier Hermine, Caroline Besson

Blood (2023) 142 (Supplement 1): 7243.

https://doi.org/10.1182/blood-2023-188890

Published: 2023

Journal Articles

IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition

Lucien Courtois, Aurélie Cabannes-Hamy, Rathana Kim, Marine Delecourt, Antoine Pinton, Guillaume Charbonnier, Mélanie Feroul, Charlotte Smith, Giulia Tueur, Cécile Pivert, Estelle Balducci, Mathieu Simonin, Laure Hélène Angel, Salvatore Spicuglia, Nicolas Boissel, Guillaume P. Andrieu, Vahid Asnafi, Philippe Rousselot, Ludovic Lhermitte

Blood (2023) 142 (2): 158–171.

https://doi.org/10.1182/blood.2022017948

Published: 2023

Includes: Supplemental data

Journal Articles

Should Adolescents and Young Adults with Hodgkin Lymphoma be Treated As Children or Adults?

Lucille Lew-Derivry, Pauline Brice, Camille Bigenwald, Judith Landman-Parker, Thierry Leblanc, Florian Chevillon, Nicolas Boissel, Aurélie Cabannes-Hamy

Blood (2022) 140 (Supplement 1): 1749–1750.

https://doi.org/10.1182/blood-2022-157046

Published: 2022

Journal Articles

Metabolic Plasticity Reveals a Targetable Vulnerability in Leukemia

Guillaume P Andrieu, Mathieu Simonin, Aurélie Cabannes-Hamy, Etienne Lengline, Ambroise Marçais, Marie Emilie Dourthe, Nicolas Boissel, Hervé Dombret, Philippe Rousselot, Olivier Hermine, Vahid Asnafi

Blood (2022) 140 (Supplement 1): 5893–5895.

https://doi.org/10.1182/blood-2022-168665

Published: 2022

Journal Articles

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study

Patrice Chevallier, Thibault Leguay, Rathana KIM, Marc Delord, Michael Doubek, Francoise Huguet, Aurelie Cabannes-Hamy, Ulla Wartiovaara-Kautto, Colombe Saillard, Emmanuel Raffoux, Thomas Cluzeau, Stephane Lepretre, Marie Balsat, Anna Berceanu, Nicolas Boissel, Claude Gardin, Emmanuelle Clappier, Herve Dombret, Philippe Rousselot

Blood (2022) 140 (Supplement 1): 6114–6116.

https://doi.org/10.1182/blood-2022-166035

Published: 2022

Journal Articles

Intra-Tumor Heterogeneity in Acute Myeloid Leukemia (AML): Results from a Real Life Cohort

Blood (2018) 132 (Supplement 1): 1537.

https://doi.org/10.1182/blood-2018-99-111288

Published: 2018

Journal Articles

Minimal Residual Disease in Ovarian Biopsies Collected in Patients with Bone Marrow Complete Remission of Acute Lymphoblastic Leukemia

Florian Chevillon, Jean-Hugues Dalle, MD PhD, Chloé Arfeuille, PhD, Céline Chalas, Marie Passet, PharmD, Véronique Drouineaud, Stephanie Nguyen, MD PhD, Ilhem Rahal, Regis Peffault De Latour, Michael Degaud, Marion Alcantara, Aurelie Cabannes-Hamy, MD, Nicolas Boissel, MD PhD, Emmanuelle Clappier, PhD PharmD, Catherine Poirot, Nathalie Dhedin, MD

Blood (2018) 132 (Supplement 1): 916.

https://doi.org/10.1182/blood-2018-99-114153

Published: 2018

Journal Articles

Inotuzumab Ozogamicin Compassionate Use for French Pediatric Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

Charlotte Calvo, Benoit Brethon, Aurelie Cabannes-Hamy, MD, Dalila Adjaoud, MD, Benedicte Bruno, MD, Laurence Blanc, MD, Nicolas Boissel, MD PhD, Marie-Dominique Tabone, MD, Andre Baruchel, MD

Blood (2018) 132 (Supplement 1): 5203.

https://doi.org/10.1182/blood-2018-99-116360

Published: 2018

Journal Articles

Clinical Characteristics, Biological Markers and Comorbidity Indexes As Predictors of Transplant-Related Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: Which One Should We Choose?

Alienor Xhaard, MD, Renato Cunha, MD PhD, Marc Busson, Marie Robin, MD PhD, Nathalie Dhedin, MD, Tereza Coman, MD PhD, Aurelie Cabannes-Hamy, MD, Flore Sicre de Fontbrune, MD, David Michonneau, MD PhD, Gerard Socie, MD PhD, Rodrigo T. Calado, MD PhD, Regis Peffault De Latour, MD PhD

Blood (2016) 128 (22): 3478.

https://doi.org/10.1182/blood.V128.22.3478.3478

Published: 2016

Journal Articles

Incidence and Risk Factors for Central Nervous System Relapse in Very Elderly Patients over 80 with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of Two Lysa Studies

Aurelie Cabannes-Hamy, MD, Frederic Peyrade, MD, Fabrice Jardin, MD PhD, Jean-Francois Emile, Sylvie Castaigne, MD PhD, Bertrand Coiffier, MD PhD, Corinne Haioun, MD, Aurore Perrot, MD, Olivier Fitoussi, MD, Safia Chebrek, Christophe Fruchart, Julie Abraham, MD, Richard Delarue, MD, Marc Andre, MD, Gilles Salles, MD PhD, Philippe Gaulard, MD PhD, Herve Tilly, MD PhD, Catherine Thieblemont, MD PhD

Blood (2016) 128 (22): 927.

https://doi.org/10.1182/blood.V128.22.927.927

Published: 2016

NARROW

NGS-based stratification refines the risk stratification in T-ALL and identifies a very-high-risk subgroup of patients

Cerebrospinal fluid distribution and pharmacokinetics of ponatinib in Ph1 + acute lymphoblastic leukemia

NGS-Based Stratification Refines the Risk Stratification in T-ALL and Identifies a Very High-Risk Subgroup of Patients

Oncogenetic-Driven Targeted Therapy for Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia : A French ALL-Target Observatory Report

Should the Carbon Footprint of Care be Taken into Account When Choosing a Treatment for Lymphoma? a Case Application on Mantle Cell Lymphoma

IL-7 receptor expression is frequent in T-cell acute lymphoblastic leukemia and predicts sensitivity to JAK inhibition

Should Adolescents and Young Adults with Hodgkin Lymphoma be Treated As Children or Adults?

Metabolic Plasticity Reveals a Targetable Vulnerability in Leukemia

Fractionated Inotuzumab Ozogamicin Combined with Low-Intensity Chemotherapy in Older Patients with Newly Diagnosed CD22+ Philadelphia Chromosome (Ph)-Negative B-Cell Precursor (BCP) Acute Lymphoblastic Leukemia (ALL): Results of the EWALL-INO Study

Intra-Tumor Heterogeneity in Acute Myeloid Leukemia (AML): Results from a Real Life Cohort

Minimal Residual Disease in Ovarian Biopsies Collected in Patients with Bone Marrow Complete Remission of Acute Lymphoblastic Leukemia

Inotuzumab Ozogamicin Compassionate Use for French Pediatric Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia

Clinical Characteristics, Biological Markers and Comorbidity Indexes As Predictors of Transplant-Related Mortality after Allogeneic Hematopoietic Stem Cell Transplantation: Which One Should We Choose?

Incidence and Risk Factors for Central Nervous System Relapse in Very Elderly Patients over 80 with Diffuse Large B-Cell Lymphoma: A Retrospective Analysis of Two Lysa Studies

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only